News & Updates

Long-term tildrakizumab safe, effective in psoriatic patients with or without MetS

19 Jan 2021 by

The efficacy and safety of long-term tildrakizumab are comparable and maintained without evidence of reduced durability of response through 148 weeks of treatment in patients with and without metabolic syndrome (MetS), results from two phase III trials have shown.

Long-term tildrakizumab safe, effective in psoriatic patients with or without MetS

19 Jan 2021

Alfacalcidol beneficial to patients undergoing valve-replacement surgery

19 Jan 2021

Supplementation with alfacalcidol prior to valve-replacement surgery helps accelerate cardiac recovery, leading to shorter length of stay in the intensive care unit and the hospital, according to a study.

Alfacalcidol beneficial to patients undergoing valve-replacement surgery

19 Jan 2021

Diabetes mellitus, lower myocardial perfusion worsen heart failure, death risk

18 Jan 2021

Type 2 diabetes mellitus and a lowered myocardial perfusion seem to aggravate the risk of heart failure and/or all-cause mortality, a new study reports.

Diabetes mellitus, lower myocardial perfusion worsen heart failure, death risk

18 Jan 2021

Higher dulaglutide doses improve response in T2D patients uncontrolled on metformin

18 Jan 2021

Treatment with dulaglutide in type 2 diabetes (T2D) patients with inadequate response to metformin yields meaningful dose-related reductions in blood glucose and body weight without compromising safety, as shown in a study.

Higher dulaglutide doses improve response in T2D patients uncontrolled on metformin

18 Jan 2021

Oily fish, omega-3 supplements protect against type 2 diabetes

18 Jan 2021

Consumption of oily fish and use of fish oil supplements help lower the risk of developing type 2 diabetes (T2D), a study has found.

Oily fish, omega-3 supplements protect against type 2 diabetes

18 Jan 2021

Does testosterone treatment exacerbate serious injury risk?

15 Jan 2021 by

Initiation of prescription testosterone treatment does not appear to further increase the risk of serious injury for patients beyond the already high baseline risk, a study has shown.

Does testosterone treatment exacerbate serious injury risk?

15 Jan 2021

Does obesity reduce risk of death in cancer patients?

15 Jan 2021

Older obese women with cancer with minimal weight loss (WL) appear to have a lower risk of death compared to their counterparts with normal weight, results of a prospective multicentre cohort study have shown.

Does obesity reduce risk of death in cancer patients?

15 Jan 2021

Risk factors in first 1,000 days predict obesity, metabolic risk in early adolescence

14 Jan 2021

Early-life risk factors in the first 1,000 days are significantly associated with higher adiposity and cardiometabolic risk in early adolescence, suggests a study.

Risk factors in first 1,000 days predict obesity, metabolic risk in early adolescence

14 Jan 2021

Incremental statin dose-related LDL-C lowering effect in Asians lower than reported

13 Jan 2021 by

In Asian patients with dyslipidemia, statin intensity titration exerts favourable effects on low-density lipoprotein cholesterol (LDL-C) levels and goal attainment rates, although the magnitude appears to be lower than reports from clinical trials, according to a study.

Incremental statin dose-related LDL-C lowering effect in Asians lower than reported

13 Jan 2021

Eating peanuts instead of rice bars as snacks improves MetS risk in adults

13 Jan 2021

Replacing a refined-grain snack with peanuts in the habitual diet does not significantly change glycaemic or lipid parameters but improves overall metabolic syndrome (MetS) risk without inducing weight gain among adults at high risk of cardiometabolic diseases, according to a China study.

Eating peanuts instead of rice bars as snacks improves MetS risk in adults

13 Jan 2021

News & Updates

Filter by Specialty:

Specialty:

Long-term tildrakizumab safe, effective in psoriatic patients with or without MetS

Long-term tildrakizumab safe, effective in psoriatic patients with or without MetS

Alfacalcidol beneficial to patients undergoing valve-replacement surgery

Alfacalcidol beneficial to patients undergoing valve-replacement surgery

Diabetes mellitus, lower myocardial perfusion worsen heart failure, death risk

Diabetes mellitus, lower myocardial perfusion worsen heart failure, death risk

Higher dulaglutide doses improve response in T2D patients uncontrolled on metformin

Higher dulaglutide doses improve response in T2D patients uncontrolled on metformin

Oily fish, omega-3 supplements protect against type 2 diabetes

Oily fish, omega-3 supplements protect against type 2 diabetes

Does testosterone treatment exacerbate serious injury risk?

Does testosterone treatment exacerbate serious injury risk?

Does obesity reduce risk of death in cancer patients?

Does obesity reduce risk of death in cancer patients?

Risk factors in first 1,000 days predict obesity, metabolic risk in early adolescence

Risk factors in first 1,000 days predict obesity, metabolic risk in early adolescence

Incremental statin dose-related LDL-C lowering effect in Asians lower than reported

Incremental statin dose-related LDL-C lowering effect in Asians lower than reported

Eating peanuts instead of rice bars as snacks improves MetS risk in adults

Eating peanuts instead of rice bars as snacks improves MetS risk in adults